<
https://www.australianpharmacist.com.au/intranasal-vaccine-stops-infection-at-the-source/>
"
Administered to the nasal mucosa, a spike-based formulation triggers rapid
local defences that clear the COVID-19 virus where it enters.
In 2022, a year after Australia’s longest COVID-19 lockdowns, researchers from
the Centenary Institute and the University of Sydney received a grant of almost
$1 million from the NSW COVID-19 Vaccine Acceleration Research Grants Program
to develop an intranasal COVID-19 vaccine.
Now, new research has been released by the team – finding that their
formulation can stop infection in the nose before the virus spreads through the
body, and to other people.
Australian Pharmacist sat down with Dr Erica Stewart, first author and
researcher at the Centenary Institute when the work was undertaken, to discuss
how the vaccine works, its applications and why it could be the key to stopping
the spread."
Via Violet Blue’s
Threat Model - Covid: September 18, 2025
https://www.patreon.com/posts/covid-september-139158191
Cheers,
*** Xanni ***
